| Ansøgningsnr. og dato | 17184486.3 (espacenet) (Federated) (European Patent Register), 20121116 | | Patent/reg.nr. og dato | DK/EP 3301177, 20200325 | | Tilgængelighedsdato | 20180404 | | Prioritetsnr. og dato | US 201161561710 P, 20111118, US 201261615618 P, 20120326, US 201261680098 P, 20120806 | | EP publ. nr. og dato |
EP 3301177 20180404 | | Løbedag | | | Ansøger/indehaver | Alnylam Pharmaceuticals, Inc., 675 West Kendall Street
Henri A. Termeer Square
Cambridge, MA 02142, US | | Ansøgers ref. nr. | 1545740 | | Opfinder | KALLANTHOTTATHIL, Rajeev G., c/o Alnylam Pharmaceuticals, Inc.
300 Third Street, 3rd Floor
Cambridge, MA Massachusetts 02142, US,
ZIMMERMANN, Tracy, c/o Alnylam Pharmaceuticals, Inc.
300 Third Street, 3rd Floor
Cambridge, MA Massachusetts 02142, US,
MANOHARAN, Muthiah, c/o Alnylam Pharmaceuticals, Inc.
300 Third Street, 3rd Floor
Cambridge, MA Massachusetts 02142, US,
MAIER, Martin, c/o Alnylam Pharmaceuticals, Inc.
300 Third Street, 3rd Floor
Cambridge, MA Massachusetts 02142, US,
KUCHIMANCHI, Satyanarayana, c/o Alnylam Pharmaceuticals, Inc.
300 Third Street, 3rd Floor
Cambridge, MA Massachusetts 02142, US,
CHARISSE, Klaus, c/o Alnylam Pharmaceuticals, Inc.
300 Third Street, 3rd Floor
Cambridge, MA Massachusetts 02142, US | | Fuldmægtig | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 31/7125 (2006.01) , C12N 15/113 (2010.01) | | Titel/benævnelse | RNAI-MIDLER, SAMMENSÆTNINGER OG FREMGANGSMÅDER TIL ANVENDELSE DERAF TIL BEHANDLING AF TRANSTHYRETIN (TTR)-FORBUNDNE SYGDOMME | | Internationalt ansøgningsnr. | | | Internationalt publ. nr. | | | Relateret sag (certifikat) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
